Sharookh B Kapadia

Sharookh B. Kapadia is a Researcher in the Department of Infectious Diseases at Genentech, Inc., where he has worked since 2007. His work focuses on host-pathogen interactions in diseases like Hepatitis C Virus (HCV), Acute Respiratory Distress Syndrome (ARDS), and sepsis, aiming to identify novel therapeutic targets through transformative biology.

• Education
  • Ph.D. in Immunology, Washington University School of Medicine, St. Louis MO (2002)
  • B.S. in Biology and Biochemistry, Brandeis University, Waltham MA (1996)
• Research Areas
  • Host responses to Gram-negative bacteria and viral pathogens (HCV, SARS-CoV-2)
  • Mechanistic studies of antibiotic resistance and lipoprotein biosynthesis
  • Identification of inflammatory mediators in ARDS and sepsis
  • Therapeutic strategies combining host-directed and pathogen-targeted approaches
• Scientific Awards
  • Genentech Key Contributor Award (2009)
  • Gloria Rosen Postdoctoral Fellowship (American Cancer Society, 2004-2006)
  • Conference awards (International Symposium on Hepatitis C, 2004 & 2005)
  • Howard Hughes Research Fellowship (1995)
• Mentorship
  • Active postdoc mentor, emphasizing rigorous science and career development
  • Trained under renowned scientists, shaping his mentoring philosophy